First-pass extracted concept

host-directed therapies

Candidate: concept label2 source documents6 linked claims

Jump to evidence Jump to sources Jump to claims

Live refresh every 5sNext refresh in 5s

Aliases

HDTs

Evidence Snippets

paving the way for efficient host-directed therapies (HDTs) against this severely harmful pathogen.

Evidence 1Source 1DOI PubMedprovenance

Host-directed therapies (HDTs) have emerged as a promising complementary strategy, leveraging the modulation of host immune responses to combat Mycobacterium tuberculosis (Mtb).

Evidence 2Source 2DOI PubMedprovenance

Supporting Sources

Source 1primary paper2025MEDDOI PubMed

1 evidence snippet 1 linked claim Claim 1

Source 2primary paper2025MEDDOI PubMed

1 evidence snippet 5 linked claims Claim 1 Claim 2 Claim 3

Linked Claims

Claim 1combination strategysupports2025Source 2DOI PubMed

Host-directed therapies may synergize with existing antibiotics to help overcome current therapeutic limitations in tuberculosis.

Quoted textsource-backed

Furthermore, the potential for HDTs to synergize with existing antibiotics underscores their relevance in overcoming current therapeutic limitations.

Claim 2comparative advantagesupports2025Source 2DOI PubMed

Compared with conventional antibiotics, host-directed therapies can enhance therapeutic outcomes by boosting host defense mechanisms, reducing treatment duration and dosage, and minimizing resistance risk.

Quoted textsource-backed

Unlike conventional antibiotics, HDTs can enhance therapeutic outcomes by boosting host defense mechanisms, reducing treatment duration and dosage, and minimizing the risk of resistance development.

Claim 3efficacy summarysupports2025Source 2DOI PubMed

Several host-directed therapies have shown significant efficacy against multidrug-resistant Mycobacterium tuberculosis strains while mitigating excessive inflammation and lowering relapse rates.

Quoted textsource-backed

Notably, several HDTs have shown significant efficacy against multidrug-resistant (MDR) Mtb strains, while also mitigating excessive inflammation and lowering relapse rates-achievements that remain elusive with antibiotic regimens alone.

Claim 4mechanistic scopesupports2025Source 2DOI PubMed

The review frames macrophage polarization, metabolic modulation, autophagy promotion, and cell death regulation as key host-directed therapy axes for tuberculosis treatment.

Quoted textsource-backed

By integrating insights into macrophage polarization, metabolic modulation, autophagy promotion, and cell death regulation, HDTs offer innovative and multifaceted approaches to TB treatment.

Claim 5therapeutic strategysupports2025Source 1DOI PubMed

Enhancing autophagy is presented as a route toward host-directed therapies against mycobacterial pathogens.

Quoted textsource-backed

This review also systematizes promising agents that enhance autophagy to improve bacterial clearance... paving the way for efficient host-directed therapies (HDTs)

Claim 6therapeutic strategysupports2025Source 2DOI PubMed

Host-directed therapies are presented as a promising complementary strategy against Mycobacterium tuberculosis by modulating host immune responses.

Quoted textsource-backed

Host-directed therapies (HDTs) have emerged as a promising complementary strategy, leveraging the modulation of host immune responses to combat Mycobacterium tuberculosis (Mtb).